Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy

Urology

Volumn 55, Issue 1, 2000, Pages 51-57

  Djavan, Bob ^a   Bursa, Bernd ^a   Basharkhah, Ali ^a   Seitz, Christian ^a   Remzi, Mesut ^a   Ghawidel, Keywan ^a   Hruby, Stephan ^a   Marberger, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROWAVE RADIATION; PREDICTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; TRANSURETHRAL MICROWAVE THERMOTHERAPY;

AGED; AGED, 80 AND OVER; DIATHERMY; HUMANS; MALE; MICROWAVES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0033954426     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00364-7     Document Type: Article

References (15)

1. Djavan B., Roehrborn C.G., Shariat S., et al. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus α-blocker treatment of patients with benign prostatic hyperplasia. J Urol. 161:1999;139-143.
2. Djavan B., Shariat S., Fakhari M., et al. Neoadjuvant and adjuvant α-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia a randomized, prospective clinical trial . Urology. 53:1999;251-259.
3. Larson T.R., Blute M.L., Bruskewitz R.C., et al. A high efficiency microwave thermoablation system in the treatment of benign prostatic hyperplasia results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial . Urology. 51:1998;731-742.
4. de Wildt M.J.A.M., Tubaro A., Höfner K., et al. Responders and nonresponders to transurethral microwave thermotherapy a multicenter retrospective analysis . J Urol. 154:1995;1775-1778.
5. Eliasson T.U., Abramsson L.B., Pettersson G.T., et al. Responders and non-responders to treatment of benign prostatic hyperplasia with transurethral microwave thermotherapy. Scand J Urol Nephrol. 29:1995;183-191.
6. Kurita Y., Ushiyama T., Suzuki K., et al. Transrectal ultrasonography to predict the clinical outcome of transurethral microwave thermotherapy in patients with benign prostatic hyperplasia. Int J Urol. 3:1996;448-453.
7. Djavan B., Zlotta A.R., Byttebier G., et al. Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol. 160:1998;411-418.
8. Roehrborn C.G., Boyle P., Gould A.L., et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology. 53:1999;581-589.
9. Roehrborn C.G., McConnell J.D., Lieber M., et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology. 53:1999;473-480.
10. Lepor H., Wang B., Shapiro E. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology. 44:1994;199-205.
11. Hammerer P.G., McNeal J.E., Stamey T.A. Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol. 153:1995;111-114.
12. Barry M.J., Williford W.O., Chang Y., et al. Benign prostatic hyperplasia specific health status measures in clinical research how much change in the American Urological Association Symptom Index is perceptible to patients? J Urol. 154:1995;1770-1774.
13. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36.
14. Arai Y., Fukuzawa S., Terai A., et al. Transurethral microwave thermotherapy for benign prostatic hyperplasia relation between clinical response and prostate histology . Prostate. 28:1996;84-88.
15. Larson T.R., Bostwick D.G., Corica A. Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia. Urology. 47:1996;463-469.